Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea · Delayed Price · Currency is KRW 42,650
+650 (1.55%)
At close: Jul 18, 2025, 3:30 PM KST
Curiox Biosystems Revenue
Curiox Biosystems had revenue of 921.85M KRW in the quarter ending March 31, 2025, a decrease of -41.93%. This brings the company's revenue in the last twelve months to 3.92B, down -36.98% year-over-year. In the year 2024, Curiox Biosystems had annual revenue of 4.59B, down -32.41%.
Revenue (ttm)
3.92B
Revenue Growth
-36.98%
P/S Ratio
176.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
692.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.59B | -2.20B | -32.41% |
| Dec 31, 2023 | 6.79B | -449.07M | -6.21% |
| Dec 31, 2022 | 7.24B | 1.71B | 31.04% |
| Dec 31, 2021 | 5.52B | 1.14B | 25.97% |
| Dec 31, 2020 | 4.38B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |